DNA Synthesis Market Share is Expected to be USD 19.4 Billion by 2035; Rising Demand for Research in Drug Discovery to Boost Market Expansion

DNA synthesis is the natural or artificial creation of deoxyribonucleic acid (DNA) molecules. The market is expected to grow due to the increasing demand for DNA synthesis owing to its applications in molecular biology, genetic engineering, and clinical diagnostics & therapeutics. In addition, the growing demand for research in drug discovery and personalized medicine are another factors propelling growth of the global market. 

DNA Synthesis Market Segmentation Analysis:

By Services	Oligonucleotide Synthesis, Custom Oligonucleotide Synthesis, Gene Synthesis, and Others
By Application	Research & Development, Diagnostics, and Therapeutics
By End-User	Biopharmaceutical Companies, Academic & Research Institutes, and Contract Research Organizations

DNA Synthesis Market Report Highlights:

• DNA synthesis market size is expected to grow at USD 19.4 billion by 2035.
• The target market was worth USD 4.57 billion in 2024.
• Target market is expected to grow at a CAGR of 17.2%.
• North America is expected to lead the market during the forecast period.
• Asia Pacific is expected to be the fastest growing region in the market during the projected period.
• Gene synthesis services segment is expected to lead the market.
• By application, the research & development segment holds the largest DNS synthesis market share.
• On the basis end-user, the biopharmaceutical companies segment is dominating the market.

DNA Synthesis Market Dynamics:

Growth Factor	Challenge Factor	Market Trend
Rising Usage of DNA Synthesis in R&D Sector	High DNA Synthesis Costs	Surging Technological Advancements

DNA Synthesis Market Key Highlights:

• In December 2023, EVONETIX LTD, the company developing semiconductor scale technology to improve access to gene synthesis, announced the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc., a global semiconductor leader. This agreement signals the continuation of the long-standing combined work of both companies, bringing efforts to the next stage in producing a new technology benchmark that will help meet the global demand for better gene synthesis.
• In October 2023, EVONETIX LTD, the Company developing semiconductor scale technology to improve access to gene synthesis, announced its first placement of a DNA synthesis development platform for evaluation at Imperial College London. This is the Company’s first platform to be installed in an external scientific setting, which is a significant milestone as it continues to optimize its gene synthesis technology in preparation for customer use and commercialization.

DNA Synthesis Market Report Analysis:

Mechanism of DNA Synthesis:

Step	Enzyme	Function
Unwinding	DNA Helicase	Unwinds the double helix by breaking hydrogen bonds between complementary base pairs.
Primer Synthesis	RNA Primase	Synthesizes a short RNA primer on the leading and lagging strands to provide a starting point for DNA synthesis.
Elongation	DNA Polymerase	Adds complementary nucleotides to the growing daughter strand, extending from the RNA primer in a 5' to 3' direction.
Fragment Joining	DNA Ligase	Joins Okazaki fragments on the lagging strand to form a continuous DNA strand.

Browse ∼37 market data tables and ∼39 figures through ∼167 slides and in-depth TOC on “DNA Synthesis Market Size, Share, By Services, Application, End-User, and By Region - Trends, Analysis and Forecast till 2035”

For more insights into the DNA Synthesis Market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/dna-synthesis-market-5727

DNA Synthesis Market Competitive Landscape:

The major players operating in the DNA synthesis market GenScript, SYNBIO TECHNOLOGIES, Thermo Fisher Scientific Inc., DNA TwoPointO, Inc., Gene Universal, Inc., Elegen Corporation, Evonetix, TWIST BIOSCIENCE, Integrated DNA Technologies, Inc., Biomatik, Ansa Biotechnologies, 4basebio, Camena Bioscience, and AZENTA LIFE SCIENCES

Company Name	THERMO FISHER SCIENTIFIC INC.
Headquarter	Massachusetts, U.S.
CEO	Marc N. Casper
Employee Count (2024)	122,000 Employees